§ 4201. Definitions
As used in this chapter:
“Professional board” means:
(A) in the case of a dentist, the State Board of Dental Examiners so designated under
26 V.S.A. chapter 12;
(B) in the case of a physician or surgeon, the State Board of Medical Practice so designated
under 26 V.S.A. chapter 23;
(C) in the case of an osteopath, the State Board of Osteopathic Examination and Registration
so designated under 26 V.S.A. chapter 33;
(D) in the case of a nurse, the Vermont State Board of Nursing so designated under 26 V.S.A. chapter 28;
(E) in the case of a pharmacist or pharmacy, the State Board of Pharmacy so designated
under 26 V.S.A. chapter 36;
(F) in the case of a veterinarian, the State Veterinary Board so designated under 26 V.S.A. chapter 44;
(G) in the case of a hospital, laboratory, or nursing home, the Commissioner of Health
so designated under chapter 3 of this title.
(2) [Repealed.]
(3) “Board of Pharmacy” means the State Board of Pharmacy so designated under 26 V.S.A. chapter 36.
(4) “Certificate” means a certificate of approval issued to a hospital, laboratory, or
nursing home under section 4207 of this title.
(5) “Dentist” means a person authorized by law to practice dentistry in this State and
who has a license issued to the person under this chapter authorizing him or her to
use regulated drugs in connection with his or her professional practice.
(6) “Depressant or stimulant drug” means:
(A) any drug that contains any quantity of barbituric acid or any of the salts of barbituric
acid, or any derivative of barbituric acid, that is designated as habit-forming because
of its effect on the central nervous system in the rules adopted by the Department
of Health under section 4202 of this title;
(B) any drug, other than methamphetamine, that contains any quantity of amphetamine or
any of its optical isomers, any salt or amphetamine or any salt of an optical isomer
of amphetamine, that the Department of Health so designates by such rule as habit-forming
because of its effect on the central nervous system;
(C) gamma hydroxybutyric acid, including its salts, isomers, or salts of isomers;
(D) gamma butyrolactone, including 4-butyrolactone and gamma hydroxybutyric acid lactone,
including its salts, isomers, or salts of isomers, when packaged, marketed, manufactured,
or intended for human consumption;
(E) ketamine, including its salts, isomers, or salts of isomers;
(F) flunitrazepam, including its salts, isomers, or salts of isomers; and
(G) any drug, other than methamphetamine, that contains any quantity of a substance that
the Department of Health so designates by such rule as having a serious potential
for abuse arising out of its effect on the central nervous system.
(7) “Dispense” includes distribute, leave with, give away, dispose of, or deliver.
(8) “Exempt officials” includes officials of the United States, insular possessions, territories,
the District of Columbia, state, and political subdivisions.
(9) “Federal drug laws” means the laws of the United States relating to one or more of
those drugs which are defined in this chapter as regulated drugs.
(10) “Hallucinogenic drugs” means stramonium, mescaline or peyote, lysergic acid diethylamide,
and psilocybin, and all synthetic equivalents of chemicals contained in resinous extractives
of Cannabis sativa, or any salts or derivatives or compounds of any preparations or
mixtures thereof, and any other substance that is designated as habit-forming or as
having a serious potential for abuse arising out of its effect on the central nervous
system or its hallucinogenic effect in the rules adopted by the Department of Health
under section 4202 of this title.
(11) “Hospital” means an institution for the care and treatment of the sick and injured
licensed as a hospital under chapter 43 of this title and a hospital conducted, maintained,
and operated by the United States or the State of Vermont, approved under this chapter
as proper to be entrusted with the custody and use of regulated drugs under the direction
of a physician or dentist, confirmed by an official written order signed by a person
authorized to prescribe such drugs.
(12) “Laboratory” means a laboratory approved under this chapter as proper to be entrusted
with the custody and use of regulated drugs for scientific and medical purposes and
for purposes of instruction.
(13) “License” means a license to practice their profession issued to one of those persons
listed in subdivisions (1)(A) through (F) of this section by the person’s respective
professional board under the applicable laws of this State, or a license issued by
the Department of Health under section 4206 of this title to a person not subject to the jurisdiction of any such professional board.
(14) “Manufacturer” means a person authorized by law to manufacture, bottle, or pack drugs
in this State and who has a license issued to the person under this chapter to compound,
mix, cultivate, produce, or prepare regulated drugs, but does not include a pharmacy
that compounds such drugs to be sold or dispensed on prescriptions at retail.
(15)(A) “Cannabis” means all parts of the plant Cannabis sativa L., except as provided by
subdivision (B) of this subdivision (15), whether growing or harvested, and includes:
(i) the seeds of the plant;
(ii) the resin extracted from any part of the plant; and
(iii) any compound, manufacture, salt, derivative, mixture, or preparation of the plant,
its seeds, or resin.
(B) “Cannabis” does not include:
(i) the mature stalks of the plant and fiber produced from the stalks;
(ii) oil or cake made from the seeds of the plant;
(iii) any compound, manufacture, salt, derivative, mixture, or preparation of the mature
stalks, fiber, oil, or cake;
(iv) the sterilized seed of the plant that is incapable of germination; or
(v) hemp or hemp products, as defined in 6 V.S.A. § 562.
(16) “Narcotic,” “narcotics,” or “narcotic drugs” means opium, coca leaves, pethidine (isonipecaine,
meperidine), and opiates or their compound, manufacture, salt, alkaloid, or derivative,
and every substance neither chemically nor physically distinguishable from them, and
preparations containing such drugs or their derivatives, by whatever trade name identified
and whether produced directly or indirectly by extraction from substances of vegetable
origin, or independently by means of chemical synthesis or by a combination of extraction
and chemical synthesis, as the same are so designated in the rules adopted by the
Department of Health under section 4202 of this title.
(17) “Nurse” means any person authorized by law to practice nursing in this State.
(18) “Nursing home” means a facility, other than a hospital, operated for the purpose of
providing lodging, board, and nursing care to persons who are sick, have an infirmity
or disability, or are convalescing, approved under this chapter as proper to be entrusted
with the custody and use of regulated drugs prescribed for such individual patients
under its care under the direction of a physician or dentist, confirmed by an official
written order signed by a person authorized to prescribe such drugs. No nursing home
shall be granted a certificate of approval for the possession and use of such drugs
unless such nursing home has a registered nurse or a licensed practical nurse on duty
or on call 24 hours daily who will have sole responsibility for those drugs. Nothing
in this chapter shall be construed as conferring on any nursing home, convalescent
home, or home for the aged any authority, right, or privilege beyond that granted
to it by the law under which it is licensed or otherwise authorized to function.
(19) “Official written order” means an order written on a form prescribed for that purpose
by the U.S. Commissioner of Narcotics and issued by the U.S. Commissioner of Internal
Revenue, under any laws of the United States making provision therefor, if such order
forms are authorized and required by federal law, and if no such order form is provided,
then on an official form provided for that purpose by the Commissioner of Health.
(20) “Person” includes an individual, partnership, corporation, association, trust, or
other institution or entity.
(21) “Pharmacist” means any person authorized by law to practice pharmacy in this State;
but nothing in this chapter shall be construed as conferring on a person any authority,
right, or privilege that is not granted to him or her by the pharmacy laws of his
or her state.
(22) “Pharmacy” means any place registered as such by the Board of Pharmacy in which drugs,
prescriptions, or poisons are possessed for the purpose of compounding, dispensing,
or retailing, or in which drugs, prescriptions, or poisons are compounded, dispensed,
or retailed, or in which such drugs, prescriptions, or poisons are by advertising
or otherwise offered for sale at retail and which has a license issued to it under
this chapter authorizing the retail dealing of regulated drugs.
(23) “Physician” means a person authorized by law to practice medicine in this State and
who has a license issued to the person under this chapter authorizing him or her to
use regulated drugs in connection with his or her professional practice.
(24) “Practitioner” includes a physician, dentist, veterinarian, surgeon, or any other
person who may be lawfully entitled under this chapter to distribute, dispense, prescribe,
or administer regulated drugs to patients.
(25) “Prescribe” means an order for a patient made or given by a practitioner.
(26) “Prescription” means an order for a regulated drug made by a physician, physician
assistant, advanced practice registered nurse, dentist, or veterinarian licensed under
this chapter to prescribe such a drug which shall be in writing except as otherwise
specified in this subdivision. Prescriptions for such drugs shall be made to the order
of an individual patient, dated as of the day of issue and signed by the prescriber.
The prescription shall bear the full name, address, and date of birth of the patient,
or if the patient is an animal, the name and address of the owner of the animal and
the species of the animal. Such prescription shall also bear the full name, address,
and registry number of the prescriber and, unless electronically prescribed, shall
be written with ink, indelible pencil, or typewriter; if typewritten, it shall be
signed by the prescriber. A written or typewritten prescription for a controlled substance,
as defined in 21 C.F.R. Part 1308, shall contain the quantity of the drug written both in numeric and word form. If
a prescription is communicated orally, it shall be reduced promptly to writing by
the pharmacist. Nothing in this subdivision is meant to authorize the oral communication
of a prescription when a written prescription is otherwise required.
(27) “Registration” means the annual registration of licenses and certificates under this
chapter.
(28) “Registry number” means the number assigned under rules adopted by the Department
of Health to each person authorized under this chapter to use, prescribe, dispense,
possess, or administer a regulated drug in connection with his or her professional
practice.
(29) “Regulated drug” means:
(A) a narcotic drug;
(B) a depressant or stimulant drug, other than methamphetamine;
(C) a hallucinogenic drug;
(D) Ecstasy;
(E) cannabis;
(F) methamphetamine; or
(G) xylazine.
(30) “Sale” means transfer for a consideration or barter or exchange or an offer or express
or implied promise to transfer for a consideration or barter or exchange, and each
such transaction made by any person, whether as principal, proprietor, agent, servant,
or employee.
(31) “Veterinarian” means a person authorized by law to practice veterinary medicine in
this State and who has a license issued to the person under this chapter authorizing
him or her to use regulated drugs in connection with his or her professional practice.
(32) “Veterinary hospital” means an institution equipped with the technical facilities
and professional and technical personnel necessary for diagnosis and treatment of
animals suffering from sickness or injury and which hospital is further approved under
this chapter as proper to be entrusted with the custody and use of regulated drugs
which may be used only by veterinarians in their professional practice at that hospital.
(33) “Wholesaler” means a person authorized by law, when so required, to sell at wholesale
drugs in this State and further has a license issued to the person under this chapter
to supply others than consumers with drugs or preparations containing a regulated
drug that the person has not produced or prepared.
(34) “Deliver” means the actual, constructive, or attempted transfer or prescription of
a regulated drug, whether or not there exists an agency relationship.
(35) “Cocaine” means coca leaves except coca leaves and extracts of coca leaves from which
cocaine, ecgonine, and derivatives of ecgonine or their salts have been removed; cocaine,
its salts, optical and geometric isomers, and salts of isomers; ecgonine, its derivatives,
their salts, isomers, and salts of isomers; or any compound, mixture, or preparation
which contains any quantity of any of the substances referred to in this subdivision.
(36) “Heroin” includes every substance not chemically or physically distinguishable from
it and preparations containing heroin or its derivatives, by whatever name identified
and whether produced directly or indirectly by extraction from substances of vegetable
origin, or independently by means of chemical synthesis or by a combination of extraction
and chemical synthesis, as designated by the Department of Health by rule.
(37) “Lysergic acid diethylamide” includes any salts or derivatives or compounds of any
preparations or mixtures of lysergic acid diethylamide or any preparation, mixture,
or compound containing any lysergic acid diethylamide.
(38) “Ecstasy” means 3,4-methylenedioxymethamphetamine, including its salts, isomers, or
salts of isomers.
(39) “Methamphetamine” includes any quantity of the substance, its salt, isomers, salts
of isomers, optical isomers, and salts of its optical isomers.
(40) [Repealed.]
(41) “Prescription drug” means any human drug required by federal law or regulation to
be dispensed only by a prescription, including finished dosage forms and active ingredients
subject to Section 503(b) of the federal Food, Drug and Cosmetic Act.
(42) “Ultimate user” means a patient who uses a prescription drug.
(43) “Immature cannabis plant” means a female cannabis plant that has not flowered and
that does not have buds that may be observed by visual examination.
(44) “Mature cannabis plant” means a female cannabis plant that has flowered and that has
buds that may be observed by visual examination.
(45) “Approved drug-checking service provider” means a provider who complies with operating
guidelines developed by the Department of Health pursuant to section 4240a of this title.
(46) “Benchmark unlawful dosage” means the maximum recommended therapeutic dose, or maximum
daily dose, as determined by the Department by rule.
(47) “Drug-checking” means the testing of a substance to determine its chemical composition
or assist in determining whether the substance contains contaminants, toxic substances,
or hazardous compounds.
(48) “Fentanyl” means any quantity of fentanyl, including any compound, mixture, or preparation
including salts, isomers, or salts of isomers containing fentanyl. “Fentanyl” also
means fentanyl-related substances as defined in rules adopted by the Department of
Health pursuant to section 4202 of this title.
(49) “Xylazine” means any compound, mixture, or preparation including salts, isomers, or
salts of isomers containing N-(2,6- dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine. (Added 1967, No. 343 (Adj. Sess.), § 1, eff. March 23, 1968; amended 1975, No. 10, § 1, eff. 30 days from March 10, 1975; 1989, No. 100, §§ 10, 11; 2001, No. 52, § 2; 2003, No. 54, § 3; 2011, No. 27, § 1; 2013, No. 75, § 2; 2013, No. 84, § 2, eff. June 10, 2013; 2013, No. 96 (Adj. Sess.), § 97; 2013, No. 138 (Adj. Sess.), § 9; 2017, No. 86 (Adj. Sess.), § 2; 2017, No. 113 (Adj. Sess.), § 75; 2023, No. 53, § 101, eff. June 8, 2023; 2023, No. 22, § 11, eff. May 25, 2023; 2023, No. 161 (Adj. Sess.), § 56, eff. June 6, 2024; 2023, No. 125 (Adj. Sess.), § 13, eff. July 1, 2024.)